Filter posts

Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right...

In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies …

The DISARM Act Can Help Fix the Broken Antibiotics Market

In a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly …

Buzz at BIO: John Hawkins, Author of Conscience and Courage

In his soon-to-be-released book Conscience and Courage, author John Hawkins reveals the philosophy, principles, methods, …

Buzz at BIO: Dr. Julie Gerberding, Merck

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access …

Buzz at BIO: Dr. Richard Hatchett, Coalition for Epidemic Preparedness Innovations (CEPI)

Vaccines are one of our most powerful tools in the fight to prevent epidemics. Yet, the …

Buzz at BIO: Jennifer Dent, BIO Ventures for Global Health

In the inaugural taping of Buzz at BIO, Jennifer Dent, who leads BIO Ventures for …

BIO 2019 Innovation Zone Company Snapshot: Litron Laboratories

The next big medical breakthrough is on the horizon and all it takes is one …

BIO 2019 Innovation Zone Company Snapshot: HealthRhythms, Inc.

The next big medical breakthrough is on the horizon and all it takes is one …

BIO 2019 Innovation Zone Company Snapshot: Trellis Biosciences

The next big medical breakthrough is on the horizon and all it takes is one …

New BIO Report on State of Innovation for Alzheimer’s Disease Therapeutics

Today, BIO released a new report: The State of Innovation in Highly Prevalent Chronic Diseases …